Deerfield Management Company, L.P. (Series C) Cv Rx, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.65 - $18.61 $4.41 Million - $7.7 Million	-413,747 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.65 - $26.07 $201,393 - $358,384	13,747 Added 3.44%	413,747 $6.84 Million
Q2 2021 Aug 16, 2021	BUY	$28.0 - $28.0 $11.2 Million - $11.2 Million	400,000 New	400,000 $11.2 Million

Others Institutions Holding CVRX

# of Institutions

Shares Held

14.4M

Call Options Held

56.3K

Put Options Held

41.8K

Johnson & Johnson New Brunswick, NJ

4.1M
Shares

$56 Million
11.52% of portfolio
Nea Management Company, LLC Timonium, MD

2.37M
Shares

$32.3 Million
1.6% of portfolio
Black Rock Inc. New York, NY

876K
Shares

$11.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

824K
Shares

$11.2 Million
0.0% of portfolio
Parkman Healthcare Partners LLC Stamford, CT

683K
Shares

$9.31 Million
0.85% of portfolio

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $281M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account